| Literature DB >> 28833046 |
Allison K Ehrlich1, Jamie M Pennington1, Susan Tilton1, Xisheng Wang1,2, Nikki B Marshall1,3, Diana Rohlman1, Castle Funatake1,4, Sumit Punj1,5, Edmond O'Donnell1,6, Zhen Yu1,7, Siva K Kolluri1, Nancy I Kerkvliet1.
Abstract
Activation of the aryl hydrocarbon receptor (AhR) by immunosuppressive ligands promotes the development of regulatory T (Treg) cells. Although AhR-induced Foxp3+ Treg cells have been well studied, much less is known about the development and fate of AhR-induced Type 1 Treg (AhR-Tr1) cells. In the current study, we identified the unique transcriptional and functional changes in murine CD4+ T cells that accompany the differentiation of AhR-Tr1 cells during the CD4+ T-cell-dependent phase of an allospecific cytotoxic T lymphocyte (allo-CTL) response. AhR activation increased the expression of genes involved in T-cell activation, immune regulation and chemotaxis, as well as a global downregulation of genes involved in cell cycling. Increased IL-2 production was responsible for the early AhR-Tr1 activation phenotype previously characterized as CD25+ CTLA4+ GITR+ on day 2. The AhR-Tr1 phenotype was further defined by the coexpression of the immunoregulatory receptors Lag3 and Tim3 and non-overlapping expression of CCR4 and CCR9. Consistent with the increased expression of CCR9, real-time imaging showed enhanced migration of AhR-Tr1 cells to the lamina propria of the small intestine and colon. The discovery of mucosal imprinting of AhR-Tr1 cells provides an additional mechanism by which therapeutic AhR ligands can control immunopathology.Entities:
Keywords: AhR; CD4+ T cells; IL-2; Lag3; Migration; Tim3; Tr1 cells
Mesh:
Substances:
Year: 2017 PMID: 28833046 PMCID: PMC5927372 DOI: 10.1002/eji.201747121
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532